Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing blood loss in placenta accreta spectrum surgery
IRCT20201003048909N1Phase 2Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of tranexamic acid in Placenta accreta spectrum (PAS) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Estimated blood loss during and after surgery, Blood product transfusion requirement and 2 more. Started Oct 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Placenta accreta spectrum (PAS)
Beyond the preview
Go deeper on IRCT20201003048909N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201003048909N1.